海量图书期刊资源,随时随地畅享阅读乐趣
Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosisKuti, Joseph L.; Pettit, Rebecca S.; Neu, Natalie; Cies, Jeffrey J.; Lapin, Craig; Muhlebach, Marianne S.; Novak, Kimberly J.; Nguyen, Sean T.; Saiman, Lisa; Nicolau, David P. · Diagnostic Microbiology and Infectious Disease · 2015
Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from QatarSid Ahmed, Mazen A; Abdel Hadi, Hamad; Hassan, Abubaker A I; Abu Jarir, Sulieman; Al-Maslamani, Muna A; Eltai, Nahla Omer; Dousa, Khalid M; Hujer, Andrea M; Sultan, Ali A; Soderquist, Bo; Bonomo, Robert A; Ibrahim, Emad Bashir; Jass, Jana; Omrani, Ali S · Journal of Antimicrobial Chemotherapy · 2019
Activity of Ceftolozane/tazobactam (C/T) and Ceftazidime/avibactam (CZA) against Extended-spectrum Β-lactamase (ESBL)-producing Enterobacteriaceae and Multidrug-resistant (MDR) Pseudomonas aeruginosa IsolatesHirsch, Elizabeth B; Zucchi, Paola; Cheung, Nicole; Krevolin, Kyle; Emery, Christopher; Bias, Tiffany · Open Forum Infectious Diseases · 2017
2383. <i>In Vitro</i> Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible <i>Pseudomonas aeruginosa</i> Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD, 2007–2017Walkty, Andrew; Adam, Heather J; Baxter, Melanie; Lagace-Wiens, Philippe; Karlowsky, James; Hoban, Daryl; Zhanel, George · Open Forum Infectious Diseases · 2018
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Jean, Shio-Shin; Lu, Min-Chi; Shi, Zhi-Yuan; Tseng, Shu-Hui; Wu, Ting-Shu; Lu, Po-Liang; Shao, Pei-Lan; Ko, Wen-Chien; Wang, Fu-Der; Hsueh, Po-Ren · Infection and Drug Resistance · 2018
In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patientsMassip, Clémence; Mathieu, Chloé; Gaudru, Cécile; Miaut, Véronique; Floch, Pauline; Oswald, Eric; Segonds, Christine; Guet-Revillet, Hélène · Journal of Antimicrobial Chemotherapy · 2018
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patientsBaklouti, Sarah; Massip, Clémence; Mane, Camille; Guet-Revillet, Hélène; Murris, Marlène; Concordet, Didier; Gandia, Peggy · Journal of Antimicrobial Chemotherapy · 2019
Antifungal Lock TherapyWalraven, C. J.; Lee, S. A. · Antimicrobial Agents and Chemotherapy · 2013
Combination Antifungal TherapyJohnson, M. D.; MacDougall, C.; Ostrosky-Zeichner, L.; Perfect, J. R.; Rex, J. H. · Antimicrobial Agents and Chemotherapy · 2004
Updated Functional Classification of -LactamasesBush, K.; Jacoby, G. A. · Antimicrobial Agents and Chemotherapy · 2010
Resistance Plasmid Families in EnterobacteriaceaeCarattoli, A. · Antimicrobial Agents and Chemotherapy · 2009
Beta-lactamase-producing enterococci.Murray, B E · Antimicrobial Agents and Chemotherapy · 1992
qnr Gene NomenclatureJacoby, G.; Cattoir, V.; Hooper, D.; Martinez-Martinez, L.; Nordmann, P.; Pascual, A.; Poirel, L.; Wang, M. · Antimicrobial Agents and Chemotherapy · 2008
Sophorolipids Having Enhanced Antibacterial ActivityShah, V.; Badia, D.; Ratsep, P. · Antimicrobial Agents and Chemotherapy · 2007
Tetracycline resistance in Peptostreptococcus species.Roberts, M C · Antimicrobial Agents and Chemotherapy · 1991